Literature DB >> 22474263

Identifying risk factors for venous thromboembolism.

Richard H White.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22474263     DOI： 10.1161/CIRCULATIONAHA.112.102814

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.

Authors:  Scott D Grosse; Richard E Nelson; Kwame A Nyarko; Lisa C Richardson; Gary E Raskob
Journal:  Thromb Res       Date:  2015-11-24       Impact factor: 3.944

Review 2.  Direct oral anticoagulants for the treatment of unprovoked venous thromboembolism: a meta-analysis of randomised controlled trials.

Authors:  Matteo N D Di Minno; Pasquale Ambrosino; Roberta Lupoli; Alessandro Di Minno; Francesco Dentali
Journal:  Blood Transfus       Date:  2014-11-25       Impact factor: 3.443

Review 3.  Can thrombus age guide thrombolytic therapy?

Authors:  Christopher Czaplicki; Hassan Albadawi; Sasan Partovi; Ripal T Gandhi; Keith Quencer; Amy R Deipolyi; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

4.  Clustering patterns of comorbidities associated with in-hospital death in hospitalizations of US adults with venous thromboembolism.

Authors:  James Tsai; Althea M Grant; J Michael Soucie; Amy Helwig; Hussain R Yusuf; Sheree L Boulet; Nimia L Reyes; Hani K Atrash
Journal:  Int J Med Sci       Date:  2013-08-19       Impact factor: 3.738

5.  Determinants of venous thromboembolism among hospitalizations of US adults: a multilevel analysis.

Authors:  James Tsai; Althea M Grant; Michele G Beckman; Scott D Grosse; Hussain R Yusuf; Lisa C Richardson
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

6.  Venous thromboembolism and persistent pulmonary hypertension in cancer patients: a cross-sectional study.

Authors:  Siegfried Wieshammer; Jens Dreyhaupt; Dirk Müller; Felix Momm; Andreas Jakob
Journal:  Thromb J       Date:  2016-02-08

Review 7.  Magnitudes of Risk Factors of Venous Thromboembolism and Quality of Anticoagulant Therapy in Ethiopia: A Systematic Review.

Authors:  Bekalu Kebede; Tirsit Ketsela
Journal:  Vasc Health Risk Manag       Date:  2022-04-11

8.  Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery.

Authors:  Christian Wurnig; Andreas Clemens; Helmuth Rauscher; Eva Kleine; Martin Feuring; Reinhard Windhager; Josef Grohs
Journal:  Thromb J       Date:  2015-11-26

9.  Venous Thromboembolism Prophylaxis: Need for Continuous Assessment Due to Changes in Risk During the Same Hospitalization.

Authors:  Rahul Chaudhary; Robert Kirchoff; Thomas Kingsley; James S Newman; Damon E Houghton; Robert D McBane
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-03-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.